v3.25.1
CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
CURRENT ASSETS    
Cash and cash equivalents $ 134,336 $ 154,571
Patient accounts receivable, net 140,370 131,802
Prepaid expenses and other current assets 29,927 26,137
Total current assets 304,633 312,510
NONCURRENT ASSETS    
Property and equipment, net 163,718 166,041
Right-of-use assets 148,068 147,878
Intangible assets, net 187,333 190,799
Goodwill 1,293,346 1,293,346
Other noncurrent assets 7,574 7,724
Total noncurrent assets 1,800,039 1,805,788
Total assets 2,104,672 2,118,298
CURRENT LIABILITIES    
Accounts payable 7,415 7,242
Accrued payroll expenses 99,922 117,461
Other accrued expenses 43,245 46,942
Operating lease liabilities, current 47,301 49,449
Other current liabilities 9,502 7,792
Total current liabilities 207,385 228,886
NONCURRENT LIABILITIES    
Long-term debt, net 276,322 279,790
Operating lease liabilities, noncurrent 149,391 148,699
Deferred tax liability, net 14,221 14,329
Other noncurrent liabilities 254 309
Total noncurrent liabilities 440,188 443,127
Total liabilities 647,573 672,013
COMMITMENTS AND CONTINGENCIES (see Note 11)
STOCKHOLDERS' EQUITY    
Preferred stock - par value $0.01 per share; 25,000 shares authorized as of March 31, 2025 and December 31, 2024; 0 shares issued and outstanding as of March 31, 2025 and December 31, 2024 0 0
Common stock - par value $0.01 per share; 800,000 shares authorized as of March 31, 2025 and December 31, 2024; 388,826 and 382,735 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 3,888 3,827
Additional paid-in capital 2,270,179 2,259,818
Accumulated other comprehensive income 612 929
Accumulated deficit (817,580) (818,289)
Total stockholders' equity 1,457,099 1,446,285
Total liabilities and stockholders' equity $ 2,104,672 $ 2,118,298